Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	TPR ZBTB33 GON4L ZNF318 ARID1A KCNIP3 SKIL ASCL3 IFI16 ZNF354B DICER1 TFAP2C ZFPM2 HIRA BPTF NCOR1 PARP1 RIF1 BEND6 RESF1 ZNF608 ZFHX3 HCFC2	2.34e-05	1413	130	23	GO:1902679
GeneOntologyBiologicalProcess	epigenetic regulation of gene expression	TPR ZDBF2 ARID1A ATAD2 IFI16 DICER1 TFAP2C RIF1 RESF1 LRIF1	4.69e-05	330	130	10	GO:0040029
GeneOntologyBiologicalProcess	chromatin organization	TPR ASH1L ZDBF2 ARID1A ATAD2 IFI16 DICER1 TFAP2C HIRA BPTF NCOR1 RIF1 PRDM9 BRD8 RESF1 HCFC2 LRIF1	4.86e-05	896	130	17	GO:0006325
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	TPR ZBTB33 GON4L ZNF318 ARID1A KCNIP3 SKIL ASCL3 IFI16 ZNF354B DICER1 TFAP2C ZFPM2 HIRA BPTF NCOR1 PARP1 RIF1 BEND6 ZNF608 ZFHX3 HCFC2	6.06e-05	1399	130	22	GO:0045892
GeneOntologyBiologicalProcess	chromatin remodeling	TPR ASH1L ZDBF2 ARID1A ATAD2 IFI16 DICER1 TFAP2C HIRA BPTF RIF1 PRDM9 RESF1 HCFC2 LRIF1	6.81e-05	741	130	15	GO:0006338
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	TPR ZBTB33 ARID1A KCNIP3 SKIL ASCL3 IFI16 ZNF354B DICER1 TFAP2C ZFPM2 BPTF NCOR1 PARP1 RIF1 ZNF608 ZFHX3 HCFC2	1.09e-04	1053	130	18	GO:0000122
Domain	BROMODOMAIN_1	ASH1L ATAD2 SP110 BRWD3 BPTF BRD8	2.36e-07	37	134	6	PS00633
Domain	BROMODOMAIN_2	ASH1L ATAD2 SP110 BRWD3 BPTF BRD8	4.46e-07	41	134	6	PS50014
Domain	Bromodomain	ASH1L ATAD2 SP110 BRWD3 BPTF BRD8	5.17e-07	42	134	6	IPR001487
Domain	BROMO	ASH1L ATAD2 SP110 BRWD3 BPTF BRD8	5.17e-07	42	134	6	SM00297
Domain	-	ASH1L ATAD2 SP110 BRWD3 BPTF BRD8	5.17e-07	42	134	6	1.20.920.10
Domain	Bromodomain	ASH1L ATAD2 BRWD3 BPTF BRD8	7.32e-06	38	134	5	PF00439
Domain	SPAN-X	SPANXN2 SPANXN1 SPANXN3	4.18e-05	10	134	3	PF07458
Domain	SPAN-X_fam	SPANXN2 SPANXN1 SPANXN3	4.18e-05	10	134	3	IPR010007
Domain	Znf_U1	TUT7 ZNF318 ZFR ZFHX3	5.23e-05	29	134	4	IPR003604
Domain	ZnF_U1	TUT7 ZNF318 ZFR ZFHX3	5.23e-05	29	134	4	SM00451
Domain	ZnF_DBF	ZDBF2 DBF4	1.53e-04	3	134	2	SM00586
Domain	ZF_DBF4	ZDBF2 DBF4	1.53e-04	3	134	2	PS51265
Domain	Znf_DBF	ZDBF2 DBF4	1.53e-04	3	134	2	IPR006572
Domain	zf-DBF	ZDBF2 DBF4	1.53e-04	3	134	2	PF07535
Domain	ARM-type_fold	DOCK2 APOB ARID1A ELMO1 MAP3K1 PPP4R3B RIF1 PIK3CG PI4KA	7.69e-04	339	134	9	IPR016024
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	WBP11 SLCO2B1 DTL ASH1L DGKA APOB ZNF318 SSR3 ARID1A CEP128 ARPC2 POTEE BPTF NCOR1 PARP1 CHCHD3 C9orf43 DST ZNF608 SYNE2 SEC23IP ZFR BOD1L1 CEP295 POTEJ	6.82e-10	1442	140	25	35575683
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	WBP11 ZNF609 ZBTB33 TEX2 VPS13C TUT7 DTL ZDBF2 SSR3 CWC25 DICER1 SEC23IP OS9 BOD1L1 CEP295 CPSF2 CLSPN NBR1	1.06e-09	733	140	18	34672954
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR ZBTB33 ZNF318 IFI16 CCNK BPTF NCOR1 PARP1 RIF1 ZFR ZFHX3 BOD1L1	1.93e-09	283	140	12	30585729
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CUL1 KIF1B DTL ZDBF2 ZNF318 ARID1A TRIP11 PPP4R3B POTEE NCOR1 RESF1 PI4KA POTEJ CLSPN LRIF1 ZMYM6	2.25e-09	588	140	16	38580884
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 WBP11 HIVEP2 KIF1B ASH1L REV3L MED13L ARID1A SKIL CMAS TRIP11 BRWD3 PPP4R3B RNF220 PARP1 CHCHD3 DST ZNF532 SEC23IP NAV3 ANKRD24 ANKRD36	1.03e-08	1285	140	22	35914814
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ZBTB33 VPS13C KIF1B APOB ZNF318 SPECC1L TRIP11 NCOR1 RIF1 DST EFNB1 PI4KA SEC23IP ZFR ZFHX3 HCFC2 CLSPN	1.75e-08	777	140	17	35844135
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF609 ZBTB33 ASH1L ZNF318 REV3L ARID1A SKIL CMAS SP110 CALML6 DICER1 BRWD3 BPTF BRD8 RESF1 ZNF608 ZFHX3 CEP295 LONRF3 CLSPN	2.45e-08	1116	140	20	31753913
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	ASH1L CCDC168 ZNF318 ARID1A NCOR1 DST RESF1 SYNE2	3.93e-08	123	140	8	26912792
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CUL1 ZNF609 ZNF318 SSR3 ARID1A SKIL CMAS IFI16 SP110 TFAP2C HIRA BPTF NCOR1 PARP1 RIF1 BRD8 DST ZFR HCFC2 CPSF2 LRIF1	5.71e-08	1294	140	21	30804502
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR WBP11 GRIK2 GRIK3 ZNF318 SPECC1L TRIP11 HIRA ARPC2 NCOR1 PARP1 DST PI4KA SYNE2 SEC23IP ZFR CPSF2 EPB41L1	6.99e-08	963	140	18	28671696
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	DOCK2 CUL1 WBP11 ZNF609 COPS3 ZNF318 MED13L ARID1A IFI16 CCNK ELMO1 PPP4R3B BPTF NCOR1 PARP1 RESF1 ZFR BIN2 LRIF1	1.05e-07	1103	140	19	34189442
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR ZNF609 ZBTB33 ZDBF2 ZNF318 NCOR1 DST RESF1 ZNF608 ZNF532 SEC23IP ZFHX3	1.42e-07	418	140	12	34709266
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZNF609 ZBTB33 MED13L ARID1A SKIL CCNK HIRA NCOR1 BRD8 ZNF608	1.49e-07	268	140	10	33640491
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL1 TPR WBP11 MED13L CMAS IFI16 CCNK TFAP2C PPP4R3B BPTF NCOR1 PARP1 RIF1 BRD8 ZNF532 ZFR BOD1L1 CPSF2	1.50e-07	1014	140	18	32416067
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF609 ZBTB33 TUT7 ASH1L ZNF318 ARID1A SKIL ATAD2 TFAP2C BPTF NCOR1 RIF1 BRD8 DBF4 ZFR ZFHX3	1.83e-07	808	140	16	20412781
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	GON4L ZDBF2 USP37 ANKRD36B RESF1 ZNF532 ANKRD36	1.85e-07	101	140	7	10997877
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF609 HIVEP2 DTL ARID1A HIRA BPTF NCOR1 RESF1 ZNF608 ZFHX3 LRIF1	2.01e-07	351	140	11	38297188
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	VPS13C ASH1L PPP4R3B SRGAP1 PCDH11X BOD1L1 CPSF2 ZMYM6	2.13e-07	153	140	8	10718198
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 ZNF609 TEX2 VPS13C SRCIN1 DICER1 PPP4R3B DST ZNF608 ZNF532 ABCA5 CPSF2 NBR1	2.50e-07	529	140	13	14621295
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TEX2 MED13L ARID1A DICER1 BPTF NCOR1 RNF220 RIF1 TRMT10C PTPRG ZFHX3 NBR1 EPB41L1	2.90e-07	536	140	13	15840001
Pubmed	Human transcription factor protein interaction networks.	WBP11 ZNF609 ZBTB33 GON4L ZNF318 ARID1A ZFPM2 HIRA BPTF NCOR1 RIF1 BRD8 DST RESF1 ZNF608 SYNE2 ZFR ZFHX3 HCFC2 CPSF2 LRIF1	2.96e-07	1429	140	21	35140242
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TEX2 MED13L ARID1A DICER1 BPTF NCOR1 RNF220 RIF1 TRMT10C PTPRG ZFHX3 NBR1 EPB41L1	3.02e-07	538	140	13	10512203
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR WBP11 ZNF609 ZBTB33 ZDBF2 ZNF318 ARID1A CWC25 CCNK BPTF NCOR1 PARP1 CHCHD3 RIF1 BRD8 ZFR BOD1L1	3.24e-07	954	140	17	36373674
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 HIVEP2 KCNH8 VPS13C KIF1B ASH1L GRIK2 SRCIN1 ARID1A KCNIP3 BRWD3 BPTF PTPRG ZNF608 ZNF532 OS9 ZFHX3 BOD1L1 ANKRD24 NBR1 EPB41L1	5.77e-07	1489	140	21	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	GON4L ZNF318 SPECC1L SSR3 CMAS ATAD2 CCNK DICER1 TFAP2C HIRA POTEE RIF1 TRMT10C BRD8 DST PI4KA OS9 ZFHX3 HCFC2 CPSF2 EPB41L1	6.29e-07	1497	140	21	31527615
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AKAP6 TPR OGFRL1 TEX2 TUT7 DTL ASH1L DGKA APOB ZNF318 BRD8 RESF1 PI4KA BOD1L1 CEP295 BIN2 CPSF2	1.86e-06	1084	140	17	11544199
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	WBP11 ZNF609 ZBTB33 ZNF318 IFI16 HIRA NCOR1 RNF220 PARP1 RESF1 ZNF608	2.01e-06	444	140	11	34795231
Pubmed	CRL4(CDT2) targets CHK1 for PCNA-independent destruction.	CUL1 DTL CLSPN	2.21e-06	7	140	3	23109433
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ZNF609 ARID1A HIRA BPTF NCOR1 BRD8 ZFR	2.24e-06	146	140	7	23892456
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR ZBTB33 ZNF318 SPECC1L ARID1A CCNK BPTF NCOR1 BRD8 SEC23IP ZFR BOD1L1	2.48e-06	549	140	12	38280479
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	CUL1 TPR ZNF609 COPS3 ARID1A TRIP11 NCOR1 CHCHD3 RIF1 SEC23IP ZFR	2.65e-06	457	140	11	32344865
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TPR ZNF609 ATAD2 DICER1 NCOR1 CHCHD3 RIF1 SYNE2 ZFR	2.82e-06	289	140	9	23752268
Pubmed	Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.	BPTF RIF1 TNFAIP6	3.52e-06	8	140	3	23143601
Pubmed	The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids.	SPANXN2 SPANXN1 SPANXN3	3.52e-06	8	140	3	14973187
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR WBP11 ZNF318 SPECC1L DICER1 ARPC2 BPTF PARP1 CHCHD3 RIF1 DST EFNB1 PI4KA SYNE2 ZFR CPSF2	4.00e-06	1024	140	16	24711643
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	WBP11 ZNF609 ARID1A USP31 PPP4R3B NCOR1 PARP1 RIF1 TRMT10C PTPRG PI4KA CSPG5 SYNE2 CPSF2 NBR1 EPB41L1	5.42e-06	1049	140	16	27880917
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	TPR WBP11 ZNF318 ARID1A CCNK RIF1 BRD8 DST ZFR BOD1L1 POTEJ	6.97e-06	506	140	11	30890647
Pubmed	Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesis.	SPANXN2 SPANXN1 SPANXN3	7.50e-06	10	140	3	17012309
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	CUL1 TPR ZBTB33 REV3L SKIL HIRA BPTF NCOR1 RIF1 BRD8 PI4KA ZFR CPSF2 NBR1	1.01e-05	857	140	14	25609649
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	ASH1L ATAD2 SP110 BPTF BRD8	1.35e-05	75	140	5	25593309
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	TPR ZBTB33 ZNF318 POTEE BPTF PARP1 ZFR POTEJ	1.51e-05	271	140	8	32433965
Pubmed	Antigen Availability and DOCK2-Driven Motility Govern CD4+ T Cell Interactions with Dendritic Cells In Vivo.	DOCK2 PIK3CG	1.61e-05	2	140	2	28607113
Pubmed	Reciprocal regulation of Rag expression in thymocytes by the zinc-finger proteins, Zfp608 and Zfp609.	ZNF609 ZNF608	1.61e-05	2	140	2	23076336
Pubmed	GluR7 is an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses.	GRIK2 GRIK3	1.61e-05	2	140	2	17620617
Pubmed	The NCoR Co-repressor Interacts with the Kaiso Transcription Factor through a Mechanism Different from That of BCL6 Interaction.	ZBTB33 NCOR1	1.61e-05	2	140	2	36786995
Pubmed	Atypical functional properties of GluK3-containing kainate receptors.	GRIK2 GRIK3	1.61e-05	2	140	2	20007474
Pubmed	Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms.	DOCK2 ELMO1	1.61e-05	2	140	2	22331897
Pubmed	Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis.	GRIK2 EPB41L1	1.61e-05	2	140	2	23400781
Pubmed	Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.	GRIK2 GRIK3	1.61e-05	2	140	2	15094479
Pubmed	Essential role of Elmo1 in Dock2-dependent lymphocyte migration.	DOCK2 ELMO1	1.61e-05	2	140	2	24821968
Pubmed	Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.	DOCK2 PIK3CG	1.61e-05	2	140	2	15357953
Pubmed	A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress.	DOCK2 PIK3CG	1.61e-05	2	140	2	17325199
Pubmed	Structure of the DOCK2-ELMO1 complex provides insights into regulation of the auto-inhibited state.	DOCK2 ELMO1	1.61e-05	2	140	2	32651375
Pubmed	Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells.	POTEE POTEJ	1.61e-05	2	140	2	18447647
Pubmed	DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1.	DOCK2 ELMO1	1.61e-05	2	140	2	12829596
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZNF609 SPECC1L MED13L ARID1A IFI16 SP110 HIRA RIF1 ZFR BOD1L1	1.62e-05	453	140	10	29656893
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TPR ARID1A CMAS BPTF PARP1 RIF1 CPSF2	1.94e-05	203	140	7	22083510
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	SLCO2B1 APOB ATAD2 CHCHD3 PIEZO2 EFNB1 PTPRG PI4KA PCDH11X FYB1 EPB41L1	2.07e-05	569	140	11	30639242
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ARHGAP42 DOCK2 TPR WBP11 ZBTB33 SSR3 ELMO1 POTEE CHCHD3 RIF1 TRMT10C SRGAP1 ZFR CPSF2	2.12e-05	916	140	14	32203420
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TPR ZNF609 DTL GRIK2 ZDBF2 SSR3 MED13L ATAD2 DICER1 TFAP2C PARP1 CHCHD3 BRD8 BEND6 DBF4 HCFC2 CLSPN	2.59e-05	1327	140	17	32694731
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TPR ZNF609 ARID1A NCOR1 PARP1 ZFR ZFHX3	3.25e-05	220	140	7	35785414
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	CUL1 TEX2 VPS13C TUT7 DTL ZDBF2 CMAS TRIP11 POTEE PARP1 CHCHD3 TRMT10C DST PI4KA SYNE2 SEC23IP ZFR NBR1	3.37e-05	1496	140	18	32877691
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZNF609 GON4L COPS3 ARID1A ZFPM2 PARP1 RESF1 ZNF608 SYNE2	3.60e-05	398	140	9	35016035
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	AKAP6 KIF1B DST SYNE2 NBR1	3.65e-05	92	140	5	15840729
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CUL1 COL5A2 WBP11 TUT7 APOB SPECC1L SSR3 CWC25 CCNK DICER1 MAP3K1 ANKRD36B PARP1 RIF1 TRMT10C POTEJ CPSF2	3.90e-05	1371	140	17	36244648
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KCNH8 NCOR1 RIF1 DST RESF1 PCDH11X CEP295	4.67e-05	233	140	7	37704626
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 TEX2 KIF1B DTL TRIP11 USP31 DST RESF1 PI4KA SRGAP1 SYNE2 BOD1L1 EPB41L1	4.79e-05	861	140	13	36931259
Pubmed	HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication.	HIVEP2 DICER1	4.81e-05	3	140	2	30682089
Pubmed	Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.	MAP3K1 NCOR1	4.81e-05	3	140	2	11971970
Pubmed	CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.	DOCK2 PIK3CG	4.81e-05	3	140	2	19451552
Pubmed	The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain.	GRIK2 GRIK3	4.81e-05	3	140	2	31513786
Pubmed	DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.	CUL1 ARID1A	4.81e-05	3	140	2	26400522
Pubmed	DICER and ZRF1 contribute to chromatin decondensation during nucleotide excision repair.	DICER1 PARP1	4.81e-05	3	140	2	28402505
Pubmed	Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.	DOCK2 ELMO1	4.81e-05	3	140	2	23525077
Pubmed	Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice.	GRIK2 GRIK3	4.81e-05	3	140	2	9880586
Pubmed	Evolution and expression of chimeric POTE-actin genes in the human genome.	POTEE POTEJ	4.81e-05	3	140	2	17101985
Pubmed	Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3.	GRIK2 GRIK3	4.81e-05	3	140	2	32567721
Pubmed	Differential trafficking of GluR7 kainate receptor subunit splice variants.	GRIK2 GRIK3	4.81e-05	3	140	2	15805114
Pubmed	A protein interaction landscape of breast cancer.	TPR COPS3 SPECC1L ARID1A CMAS TRIP11 PARP1 DST PI4KA OS9 EPB41L1	5.51e-05	634	140	11	34591612
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CUL1 HIVEP2 ZBTB33 DTL COPS3 SSR3 USP37 DICER1 RNF220 PARP1 TRMT10C PIK3CG ZFR ZMYM6	5.78e-05	1005	140	14	19615732
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZDBF2 REV3L ARID1A TRIP11 ANKRD36B NCOR1 CHCHD3 SYNE2 SEC23IP CEP295 POTEJ	5.82e-05	638	140	11	31182584
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED13L ARID1A BPTF RIF1 BRD8 RESF1	6.18e-05	167	140	6	20362541
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CUL1 TPR VPS13C APOB COPS3 ATAD2 DICER1 ARPC2 PARP1 CHCHD3 RIF1 TRMT10C PI4KA SEC23IP ZFR BOD1L1 NBR1	6.28e-05	1425	140	17	30948266
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR ZBTB33 BPTF NCOR1 PARP1 RIF1 BOD1L1 CPSF2	6.35e-05	332	140	8	32786267
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	WBP11 ZNF609 SAMD9 TUT7 DGKA GON4L SSR3 DICER1 DST CLSPN EPB41L1	6.87e-05	650	140	11	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR TUT7 ZNF318 ARID1A ATAD2 DICER1 BPTF RIF1 DST SYNE2 ZFR	7.16e-05	653	140	11	22586326
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	TPR ZBTB33 DTL CWC25 BPTF PARP1 RIF1	7.27e-05	250	140	7	33536335
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR KIF1B ZNF318 ATAD2 IFI16 CCNK BPTF NCOR1 RIF1 BRD8 DBF4 CPSF2	7.37e-05	774	140	12	15302935
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	CCNK BPTF PARP1 ZFR BOD1L1 HCFC2 CPSF2	7.46e-05	251	140	7	31076518
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ARID1A HIRA BPTF NCOR1 CHCHD3 RIF1 PRKACG CPSF2	7.65e-05	341	140	8	32971831
Pubmed	Protein phosphatase 1γ isoforms linked interactions in the brain.	WBP11 ZDBF2 ZNF318 RIF1	8.42e-05	57	140	4	23080069
Pubmed	Mechanosensory hair cells express two molecularly distinct mechanotransduction channels.	TMC2 PIEZO2	9.60e-05	4	140	2	27893727
Pubmed	Distribution of kainate receptor subunits at hippocampal mossy fiber synapses.	GRIK2 GRIK3	9.60e-05	4	140	2	12954862
Pubmed	A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs.	DOCK2 ELMO1	9.60e-05	4	140	2	15723800
Pubmed	Cdc7-Dbf4 and the human S checkpoint response to UVC.	DBF4 CLSPN	9.60e-05	4	140	2	17276990
Pubmed	Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool.	GRIK2 GRIK3	9.60e-05	4	140	2	15513934
Pubmed	Kainate receptors act as conditional amplifiers of spike transmission at hippocampal mossy fiber synapses.	GRIK2 GRIK3	9.60e-05	4	140	2	19369569
Pubmed	HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis.	DOCK2 ELMO1	9.60e-05	4	140	2	14737186
Pubmed	The mouse interferon-inducible gene Ifi204 product interacts with the Tpr protein, a component of the nuclear pore complex.	TPR IFI16	9.60e-05	4	140	2	12513910
Pubmed	MicroRNAs are mediators of androgen action in prostate and muscle.	DICER1 NCOR1	9.60e-05	4	140	2	21048966
Interaction	NUP43 interactions	ZNF609 ASH1L GON4L ZDBF2 CCDC168 ZNF318 ARID1A ATAD2 IFI16 BPTF NCOR1 RNF220 RIF1 BRD8 DST RESF1 ZNF608 ZNF532 PI4KA SYNE2 ZFHX3 BOD1L1 HCFC2	4.39e-11	625	138	23	int:NUP43
Interaction	HDAC1 interactions	TPR ZNF609 ZBTB33 GON4L ZDBF2 COPS3 ZNF318 USP37 ARID1A SKIL CEP128 ZFPM2 BPTF NCOR1 PARP1 DST ZNF608 SYNE2 SEC23IP ZFHX3 CPSF2	2.11e-05	1108	138	21	int:HDAC1
Interaction	EGR2 interactions	ZNF609 HIVEP2 ARID1A HIRA NCOR1 RESF1 ZNF608 ZFHX3	2.37e-05	171	138	8	int:EGR2
Interaction	NGEF interactions	ARHGAP42 SSR3 CMAS CHCHD3 RIF1 HCFC2	3.59e-05	90	138	6	int:NGEF
Interaction	GRIK3 interactions	GRIK2 GRIK3 SSR3	3.64e-05	10	138	3	int:GRIK3
Interaction	ANKRD24 interactions	RIF1 ANKRD24 LRIF1	4.98e-05	11	138	3	int:ANKRD24
Interaction	HNF1B interactions	ZNF609 ARID1A HIRA BPTF NCOR1 PARP1 ZNF608 ZFHX3	5.03e-05	190	138	8	int:HNF1B
Interaction	ASF1A interactions	CUL1 ARID1A TFAP2C HIRA NCOR1 RIF1 CLSPN LRIF1 ZMYM6	5.58e-05	249	138	9	int:ASF1A
Interaction	PHIP interactions	TPR ZNF609 COPS3 IFI16 BRWD3 PARP1 ZNF608 ZFHX3	6.49e-05	197	138	8	int:PHIP
Cytoband	Xq27	SPANXN1 CNGA2	4.15e-04	10	141	2	Xq27
Cytoband	1q22	ASH1L GON4L IFI16	7.35e-04	57	141	3	1q22
Cytoband	1p34.2	CFAP57 CLSPN ZMYM6	7.35e-04	57	141	3	1p34.2
Cytoband	2q21.1	KCNIP3 POTEE POTEJ	7.73e-04	58	141	3	2q21.1
Cytoband	17q24.3	BPTF ABCA5	1.24e-03	17	141	2	17q24.3
Cytoband	14q31.1	CEP128 CPSF2	1.24e-03	17	141	2	14q31.1
Cytoband	Ensembl 112 genes in cytogenetic band chr2q11	ANKRD36C KCNIP3 ANKRD36B ANKRD36	1.31e-03	153	141	4	chr2q11
Cytoband	2q23.3	RIF1 TNFAIP6	1.55e-03	19	141	2	2q23.3
Cytoband	Ensembl 112 genes in cytogenetic band chrXq24	ZBTB33 KIAA1210 LONRF3	2.03e-03	81	141	3	chrXq24
Cytoband	Ensembl 112 genes in cytogenetic band chr1p34	GRIK3 RNF220 CFAP57 CLSPN ZMYM6	2.22e-03	294	141	5	chr1p34
GeneFamily	Zinc fingers DBF-type	ZDBF2 DBF4	7.33e-05	3	90	2	75
GeneFamily	Glutamate ionotropic receptor kainate type subunits	GRIK2 GRIK3	2.43e-04	5	90	2	1199
GeneFamily	Ankyrin repeat domain containing	ANKRD36C ANKRD36B POTEE ANKRD24 ANKRD36 POTEJ	1.32e-03	242	90	6	403
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEE POTEJ	1.84e-03	13	90	2	685
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF609 HIVEP2 ZBTB33 ZNF318 ZNF354B ZFPM2 PRDM9 ZNF608 ZNF532 ZFHX3	2.99e-03	718	90	10	28
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	AKAP6 KCNH8 APLP1 GRIK2 GRIK3 SRCIN1 ZNF318 REV3L MED13L DICER1 ZFPM2 ANKRD36B PIEZO2 SRGAP1 CSPG5 PCDH11X NAV3 ZFHX3 BOD1L1 ANKRD36 HCFC2 EPB41L1 ARMH4	2.26e-08	1106	140	23	M39071
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	DOCK2 TPR ZNF609 HIVEP2 SAMD9 VPS13C ASH1L DGKA ITGA1 REV3L ARID1A IFI16 SP110 DICER1 ARPC2 PPP4R3B BPTF NCOR1 PARP1 RIF1 RESF1 GVINP1 ZFR BOD1L1 BIN2 FYB1	8.52e-08	1492	140	26	M40023
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	VPS13C TUT7 REV3L ATAD2 IFI16 ZNF354B TRIP11 BPTF RIF1 TRMT10C PIEZO2 RESF1 ABCA5 DBF4 SYNE2 FYB1	4.77e-07	656	140	16	M18979
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	CUL1 HIVEP2 ZNF318 REV3L MED13L BPTF RIF1 BRD8 DST NAV3	5.14e-06	300	140	10	M8702
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	VPS13C USP37 ARID1A ATAD2 BPTF NCOR1 RIF1 PIK3CG	5.84e-06	180	140	8	M8239
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ARHGAP42 TEX2 KIF1B DGKA SRCIN1 KCNIP3 SKIL CEP128 TRIP11 HIRA NCOR1 DST SRGAP1 NAV3 ZFR ZFHX3 CEP295 TNFAIP6 EPB41L1	6.70e-06	1102	140	19	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ARHGAP42 TEX2 KIF1B DGKA SRCIN1 KCNIP3 SKIL CEP128 TRIP11 HIRA NCOR1 DST SRGAP1 NAV3 ZFR ZFHX3 CEP295 TNFAIP6 EPB41L1	8.86e-06	1124	140	19	MM1070
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	TPR KIF1B DTL SSR3 ATAD2 IFI16 TRIP11 PPP4R3B CHCHD3 RIF1 RESF1 DBF4 CPSF2 LRIF1	9.61e-06	644	140	14	M10501
Coexpression	GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN	DOCK2 ASH1L CMAS TG CHCHD3 TRAT1 BIN2 TNFAIP6	1.13e-05	197	140	8	M7258
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	CNNM2 ZNF318 MAP3K1 BPTF RESF1 GVINP1 SYNE2 FYB1	1.26e-05	200	140	8	M8620
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	OGFRL1 MED13L CMAS BRD8 FIG4 DBF4 SEC23IP CPSF2	1.26e-05	200	140	8	M8959
Coexpression	ZHENG_BOUND_BY_FOXP3	HIVEP2 IFI16 ELMO1 MAP3K1 TG BEND6 GVINP1 ZNF608 TRAT1 PIK3CG SYNE2 FYB1	1.57e-05	498	140	12	M1741
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	AKAP6 ITGA1 MED13L DST PTPRG ZFHX3 ANKRD36	2.05e-05	155	140	7	M39246
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TPR OGFRL1 SAMD9 SSR3 ATAD2 IFI16 USP31 PPP4R3B RIF1 RESF1 DBF4 BOD1L1 CPSF2 LRIF1	3.35e-05	721	140	14	M10237
Coexpression	CUI_TCF21_TARGETS_2_DN	HIVEP2 TEX2 TUT7 KIF1B ASH1L IFI16 TRIP11 PPP4R3B NCOR1 DST EFNB1 PTPRG GVINP1 ABCA5 ZFR	5.45e-05	854	140	15	M1533
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CUL1 COL5A2 HIVEP2 SPECC1L REV3L MED13L DICER1 HIRA BPTF RIF1 DST DBF4 SYNE2 NAV3 ZFHX3	5.60e-05	856	140	15	M4500
Coexpression	GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN	CUL1 COL5A2 TMC2 DTL APLP1 GRIK2 PRKACG	6.14e-05	184	140	7	M4907
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	DTL USP37 SKIL ATAD2 ANKRD36B ZNF532 ABCA5	8.83e-05	195	140	7	M13736
Coexpression	ZHENG_BOUND_BY_FOXP3	HIVEP2 ELMO1 MAP3K1 TG BEND6 GVINP1 ZNF608 TRAT1 PIK3CG SYNE2 FYB1	9.17e-05	507	140	11	MM1030
Coexpression	GSE45365_CD8A_DC_VS_CD11B_DC_UP	COL5A2 SAMD9 ARPC2 NCOR1 RIF1 DBF4 BOD1L1	9.42e-05	197	140	7	M9997
Coexpression	GSE360_CTRL_VS_L_MAJOR_DC_UP	SLCO2B1 ITGA1 IFI16 ELMO1 PIK3CG SEC23IP ZFHX3	1.00e-04	199	140	7	M5145
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	ZNF609 VPS13C PAIP2B ZNF318 MAP3K1 PI4KA FYB1	1.03e-04	200	140	7	M4524
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	CUL1 TPR HIVEP2 ZDBF2 SSR3 SP110 ARMH4	1.03e-04	200	140	7	M3510
Coexpression	GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	CUL1 TUT7 DGKA ZDBF2 SP110 BRWD3 HCFC2	1.03e-04	200	140	7	M3513
Coexpression	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP	AKAP6 COL5A2 HIVEP2 ZDBF2 C4orf54 PIK3CG SRGAP1	1.03e-04	200	140	7	M6795
Coexpression	LEE_DIFFERENTIATING_T_LYMPHOCYTE	DOCK2 DGKA SP110 DICER1 TRAT1 PIK3CG FYB1	1.07e-04	201	140	7	M2200
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	DOCK2 ZNF609 SAMD9 ITGA1 ARID1A IFI16 SP110 ARPC2 BPTF RESF1 GVINP1 TRAT1 SYNE2 BIN2 FYB1	1.12e-04	911	140	15	M40038
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	WBP11 DTL ASH1L DGKA ARID1A SKIL IFI16 MAP3K1 SLC26A8 TRAT1 DBF4 OS9 CPSF2 FYB1 NBR1 LRIF1	1.20e-04	1024	140	16	M1742
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	HIVEP2 KIF1B ITGA1 DST SRGAP1 ANKRD36 ARMH4	1.48e-04	212	140	7	M39221
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	DTL ANKRD36C USP37 ATAD2 MAP3K1 ANKRD36B RIF1 TRMT10C BRD8 DBF4 PI4KA SYNE2 CEP295 ANKRD36 CLSPN	1.56e-04	939	140	15	M45768
Coexpression	MURARO_PANCREAS_BETA_CELL	HIVEP2 ZBTB33 VPS13C ASH1L ZNF318 SPECC1L TRIP11 DICER1 ELMO1 DST ABCA5 PI4KA SYNE2 HCFC2 EPB41L1	1.69e-04	946	140	15	M39169
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	WBP11 DTL ASH1L DGKA ARID1A SKIL IFI16 MAP3K1 SLC26A8 TRAT1 DBF4 OS9 CPSF2 FYB1 NBR1 LRIF1	2.02e-04	1072	140	16	MM1031
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	TPR OGFRL1 ZBTB33 DTL ZDBF2 REV3L ARID1A ATAD2 CEP128 CCNK DICER1 TFAP2C PPP4R3B BPTF RIF1 TRMT10C PRDM9 DBF4 SYNE2 ZFHX3 BOD1L1 CEP295 CPSF2 CLSPN LRIF1	5.00e-07	1257	138	25	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	TPR OGFRL1 ZBTB33 SLCO2B1 DTL GRIK2 ZDBF2 REV3L ARID1A ATAD2 CEP128 CCNK DICER1 TFAP2C PPP4R3B BPTF RIF1 TRMT10C PRDM9 DBF4 SYNE2 ZFHX3 BOD1L1 CEP295 CPSF2 CLSPN LRIF1	6.67e-07	1459	138	27	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	ARHGAP42 TPR OGFRL1 ZBTB33 SLCO2B1 REV3L ARID1A KCNIP3 ATAD2 CEP128 SP110 BRWD3 PPP4R3B RIF1 TRMT10C RESF1 GVINP1 DBF4 SYNE2 ZFHX3 BOD1L1 CEP295 CLSPN LRIF1	1.68e-06	1252	138	24	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	OGFRL1 REV3L DICER1 NCOR1 RIF1 SRGAP1 SYNE2 BOD1L1 CEP295 CLSPN	3.72e-05	311	138	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	ZBTB33 KIF1B ASH1L C4orf54 USP31 PIEZO2 PTPRG PCDH11X HCFC2	6.23e-05	266	138	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	ARHGAP42 TPR KIF1B DGKA REV3L IFI16 TFAP2C ELMO1 USP31 BEND6 DST PTPRG ABCA5 SRGAP1 PCDH11X ARMH4	7.13e-05	806	138	16	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	ARHGAP42 TPR DGKA REV3L IFI16 TFAP2C ELMO1 USP31 DST PCDH11X ARMH4	7.31e-05	407	138	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	OGFRL1 APLP1 GRIK2 ZDBF2 REV3L EPB41L4A DICER1 NCOR1 RIF1 DBF4 SRGAP1 LRP11 SYNE2 PCDH11X BOD1L1 CEP295 CLSPN LRIF1	7.51e-05	989	138	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	COL5A2 OGFRL1 KIF1B DTL EPB41L4A ATAD2 IFI16 CEP128 ZFPM2 NCOR1 BRD8 PIEZO2 ABCA5 PCDH11X HCFC2 CPSF2	8.60e-05	819	138	16	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000	OGFRL1 KIF1B ZDBF2 IFI16 C4orf54 BRD8 SRGAP1 CPSF2 CLSPN	1.30e-04	293	138	9	gudmap_developingKidney_e15.5_Podocyte cells_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR ZBTB33 KIF1B REV3L SKIL ELMO1 USP31 PTPRG SRGAP1 PCDH11X	1.53e-04	369	138	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	ARHGAP42 CUL1 TPR OGFRL1 ZBTB33 SLCO2B1 ZDBF2 ATAD2 SP110 BRWD3 PPP4R3B RIF1 TRMT10C RESF1 DBF4 ZFHX3 BOD1L1 CEP295 CLSPN LRIF1	1.54e-04	1241	138	20	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	COL5A2 OGFRL1 KIF1B DTL NCOR1 ABCA5 PCDH11X HCFC2 CPSF2	1.84e-04	307	138	9	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_500	ATAD2 ZFPM2 PIEZO2 ABCA5 PCDH11X	1.97e-04	82	138	5	gudmap_developingKidney_e15.5_Peripheral blastema_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	ARHGAP42 TPR KIF1B REV3L ELMO1 USP31 BEND6 SRGAP1 PCDH11X	2.08e-04	312	138	9	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500	IFI16 TFAP2C BRWD3 NCOR1 CPSF2 ARMH4	2.26e-04	132	138	6	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	KIF1B ASH1L ARID1A TFAP2C BRWD3 MAP3K1 RIF1 BRD8 EFNB1 RESF1 PTPRG SYNE2 PCDH11X ZFHX3 CEP295	2.38e-04	804	138	15	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	TPR ZBTB33 KIF1B REV3L SKIL IFI16 TFAP2C ELMO1 USP31 DST PTPRG ABCA5 SRGAP1 PCDH11X CPSF2	2.44e-04	806	138	15	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	AKAP6 ZBTB33 KIF1B ASH1L REV3L SKIL IFI16 TFAP2C USP31 RIF1 PTPRG ABCA5 LRP11 PCDH11X CPSF2	2.86e-04	818	138	15	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2	TPR HIVEP2 KIF1B DGKA REV3L SKIL RIF1 TRAT1 FYB1	2.94e-04	327	138	9	GSM538380_500
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	PPP4R3B RIF1 EFNB1 RESF1 SYNE2 ZFR NBR1	3.09e-04	197	138	7	gudmap_developingGonad_e11.5_testes_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	ZBTB33 KIF1B ASH1L REV3L SKIL USP31 RIF1 PTPRG PCDH11X	3.14e-04	330	138	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	OGFRL1 TUT7 ASH1L GON4L APLP1 ZDBF2 EPB41L4A NCOR1 RIF1 DBF4 SRGAP1 SYNE2 BOD1L1 CEP295 CLSPN	3.38e-04	831	138	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000	OGFRL1 SLCO2B1 KIF1B ZDBF2 ATAD2 IFI16 C4orf54 ELMO1 USP31 BRD8 ABCA5 SRGAP1 CPSF2 CLSPN FYB1	3.60e-04	836	138	15	gudmap_developingKidney_e15.5_Podocyte cells_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	COL5A2 USP37 IFI16 BRWD3 NCOR1 RIF1 ZFR ZFHX3 TNFAIP6 HCFC2 CPSF2	3.78e-04	492	138	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	ARHGAP42 TPR REV3L ELMO1 USP31 PCDH11X	4.33e-04	149	138	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500	EPB41L4A ATAD2 IFI16 ZFPM2 NCOR1 BRD8 PIEZO2 ABCA5 PCDH11X CPSF2	4.38e-04	421	138	10	gudmap_developingKidney_e15.5_Peripheral blastema_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	KIF1B ASH1L MAP3K1 BRD8 PTPRG SYNE2 PCDH11X CEP295	4.66e-04	277	138	8	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	COL5A2 REV3L MED13L IFI16 TFAP2C USP31 RIF1 DST PTPRG ABCA5 NAV3 ZFHX3 TNFAIP6 CPSF2	4.94e-04	769	138	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	ARHGAP42 CUL1 TPR OGFRL1 ZBTB33 SLCO2B1 ZDBF2 ATAD2 SP110 TFAP2C BRWD3 PPP4R3B RIF1 TRMT10C RESF1 DBF4 ZFHX3 BOD1L1 CEP295 CLSPN LRIF1	5.20e-04	1468	138	21	facebase_RNAseq_e10.5_MandArch_2500
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C KIF1B ASH1L APLP1 REV3L TRIP11 NCOR1 RIF1 DST ABCA5 ZFR BOD1L1	1.53e-12	195	141	12	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLCO2B1 DTL ASH1L EPB41L4A IFI16 BPTF DST EFNB1 RESF1 PTPRG ZNF608 SYNE2	2.06e-12	200	141	12	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR VPS13C REV3L TRIP11 BPTF NCOR1 BRD8 DST SYNE2 BOD1L1 ANKRD36	4.28e-11	199	141	11	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR SAMD9 VPS13C ASH1L MED13L IFI16 SP110 BPTF RESF1 SYNE2 BOD1L1	4.51e-11	200	141	11	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR VPS13C ASH1L APOB TRIP11 BRWD3 PPP4R3B NCOR1 SYNE2 ZFR	5.72e-10	191	141	10	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR VPS13C ASH1L APOB TRIP11 BRWD3 PPP4R3B NCOR1 SYNE2 ZFR	5.72e-10	191	141	10	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR VPS13C ASH1L APOB TRIP11 BRWD3 PPP4R3B NCOR1 SYNE2 ZFR	5.72e-10	191	141	10	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C KIF1B ASH1L APLP1 REV3L NCOR1 RIF1 DST ZFR BOD1L1	7.00e-10	195	141	10	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SAMD9 VPS13C TRIP11 ANKRD36B BPTF RESF1 SYNE2 ZFR BOD1L1 ANKRD36	8.53e-10	199	141	10	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARHGAP42 TPR ITGA1 USP37 BRWD3 MAP3K1 RESF1 BOD1L1 CEP295	8.50e-09	186	141	9	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL5A2 ITGA1 ELMO1 ZFPM2 PIEZO2 DST PTPRG SRGAP1 NAV3	8.90e-09	187	141	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR SAMD9 VPS13C ASH1L IFI16 RESF1 TRAT1 SYNE2 ANKRD36	1.46e-08	198	141	9	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SAMD9 GRIK2 GRIK3 ITGA1 ANKRD36C PIEZO2 ZNF608 PCDH11X ANKRD36	1.60e-08	200	141	9	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SAMD9 GRIK2 GRIK3 ITGA1 ANKRD36C PIEZO2 ZNF608 PCDH11X ANKRD36	1.60e-08	200	141	9	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLCO2B1 DTL IFI16 BPTF DST EFNB1 PTPRG ZNF608 SYNE2	1.60e-08	200	141	9	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SAMD9 GRIK2 GRIK3 ITGA1 ANKRD36C PIEZO2 ZNF608 PCDH11X ANKRD36	1.60e-08	200	141	9	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR VPS13C TUT7 ASH1L ITGA1 TRIP11 GVINP1 SYNE2	1.04e-07	178	141	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SAMD9 ASH1L SKIL IFI16 SP110 RIF1 DST SYNE2	1.28e-07	183	141	8	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	OGFRL1 SLCO2B1 ANKRD36C SKIL ELMO1 DST SRGAP1 ANKRD36	1.93e-07	193	141	8	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ASH1L DGKA ANKRD36C TRIP11 ANKRD36B BPTF RESF1 ANKRD36	2.09e-07	195	141	8	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	COVID-19-kidney-T-cells-1\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK2 DGKA IFI16 ELMO1 RESF1 TRAT1 BIN2 FYB1	2.26e-07	197	141	8	9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 SLCO2B1 VPS13C USP37 CEP128 PIK3CG ZFR ZFHX3	2.34e-07	198	141	8	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 SLCO2B1 VPS13C USP37 CEP128 PIK3CG ZFR ZFHX3	2.34e-07	198	141	8	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 SLCO2B1 VPS13C USP37 CEP128 PIK3CG ZFR ZFHX3	2.34e-07	198	141	8	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARHGAP42 COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG SRGAP1	2.34e-07	198	141	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	SAMD9 ASH1L ANKRD36C SP110 ANKRD36B RESF1 TRAT1 SYNE2	2.44e-07	199	141	8	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	DTL REV3L IFI16 BPTF DST EFNB1 PTPRG ZNF608	2.53e-07	200	141	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	SAMD9 VPS13C IFI16 SP110 BPTF RESF1 SYNE2 BOD1L1	2.53e-07	200	141	8	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 ITGA1 ELMO1 ZFPM2 PIEZO2 DST SRGAP1 NAV3	2.53e-07	200	141	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLCO2B1 DTL IFI16 BPTF DST EFNB1 PTPRG ZNF608	2.53e-07	200	141	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	VWA3A SAMD9 IFI16 SP110 TG SYNE2 FYB1	5.66e-07	152	141	7	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	COVID-19-kidney-Mito-rich_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK2 SAMD9 SPANXN2 DGKA ELMO1 BIN2 FYB1	1.82e-06	181	141	7	8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANKRD36C ANKRD36B BPTF NCOR1 EFNB1 SYNE2 CEP295	2.11e-06	185	141	7	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	DOCK2 IFI16 RESF1 TRAT1 SYNE2 BIN2 FYB1	2.26e-06	187	141	7	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ASH1L DGKA ANKRD36C RESF1 TRAT1 SYNE2 FYB1	2.34e-06	188	141	7	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	VPS13C ASH1L ITGA1 ANKRD36C MED13L SYNE2 ANKRD36	2.34e-06	188	141	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 OGFRL1 SLCO2B1 ELMO1 PIK3CG BIN2 FYB1	2.34e-06	188	141	7	0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR SAMD9 DGKA RESF1 TRAT1 SYNE2 ANKRD36	2.34e-06	188	141	7	e5c480b9a030536578f1cc91fb61738f752525b3
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	ASH1L APOB ANKRD36C RESF1 SYNE2 ANKRD36	2.43e-06	121	141	6	19333a660800b583fa27b495c1f7828e6636a257
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.51e-06	190	141	7	ba61f04fd38efae01f721ba616252d1372ff1002
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 OGFRL1 SLCO2B1 ELMO1 PIK3CG BIN2 FYB1	2.51e-06	190	141	7	7c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.51e-06	190	141	7	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.51e-06	190	141	7	b772a5d281fe016f259ddda80d6f33d949dcac2b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.51e-06	190	141	7	5a37568000dfc33fcbb59b578c1963fb7cf872ec
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.51e-06	190	141	7	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DTL ATAD2 CEP128 BIN2 CLSPN FYB1	2.51e-06	190	141	7	b65383e256b04122500b742caeed0b807793851e
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	2.51e-06	190	141	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DTL ATAD2 CEP128 BIN2 CLSPN FYB1	2.51e-06	190	141	7	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	96a7179a845d3daa046ed71fa45c51255f130a7f
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR SAMD9 DGKA RESF1 TRAT1 SYNE2 ANKRD36	2.60e-06	191	141	7	c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	1a2d5fec2bea96da2154b0aed252f1bb35102f6e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	326b4541069efedc8ab409f85bb11f77346dda90
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 DGKA ELMO1 RESF1 TRAT1 BIN2 FYB1	2.60e-06	191	141	7	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	2.60e-06	191	141	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ASH1L ANKRD36C BPTF NCOR1 BRD8 BOD1L1 ANKRD36	2.69e-06	192	141	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	2.69e-06	192	141	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 EPB41L4A IFI16 SLC1A7 ARPC2 SYNE2 BIN2	2.69e-06	192	141	7	fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 ELMO1 PIEZO2 DST PTPRG SRGAP1 NAV3	2.79e-06	193	141	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL5A2 ITGA1 ELMO1 PIEZO2 DST PTPRG SRGAP1	2.79e-06	193	141	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 ELMO1 PIEZO2 DST PTPRG SRGAP1 NAV3	2.89e-06	194	141	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A2 ITGA1 ELMO1 PIEZO2 DST PTPRG SRGAP1	2.89e-06	194	141	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HIVEP2 DGKA IFI16 RESF1 TRAT1 SYNE2 FYB1	2.89e-06	194	141	7	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGA1 ELMO1 ZFPM2 PIEZO2 DST SRGAP1 NAV3	2.89e-06	194	141	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO2B1 DTL EPB41L4A ZFPM2 USP31 EFNB1 ZNF608	2.89e-06	194	141	7	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO2B1 DTL EPB41L4A ZFPM2 USP31 EFNB1 ZNF608	2.89e-06	194	141	7	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HIVEP2 DGKA ANKRD36C RESF1 TRAT1 SYNE2 ANKRD36	2.99e-06	195	141	7	4bdedd924564a260841a9153604026b57487c83d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 SLCO2B1 IFI16 ELMO1 RESF1 BIN2 FYB1	2.99e-06	195	141	7	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HIVEP2 DGKA ANKRD36C DST RESF1 TRAT1 SYNE2	2.99e-06	195	141	7	22191d361af136942508f1553ff41a626ed982ad
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	3.09e-06	196	141	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR SAMD9 DGKA ANKRD36C CEP128 RESF1 SYNE2	3.19e-06	197	141	7	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 SLCO2B1 IFI16 ELMO1 PIK3CG BIN2 FYB1	3.19e-06	197	141	7	61ef3f417767c3f5296a26399da63e3e4f58faf8
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	3.30e-06	198	141	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 DGKA CEP128 ELMO1 RESF1 SYNE2 BIN2	3.30e-06	198	141	7	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG NAV3	3.41e-06	199	141	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	VPS13C REV3L IFI16 TRIP11 BPTF SYNE2 BOD1L1	3.41e-06	199	141	7	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR VPS13C REV3L TRIP11 BPTF SYNE2 BOD1L1	3.41e-06	199	141	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR HIVEP2 DGKA RESF1 TRAT1 SYNE2 ANKRD36	3.41e-06	199	141	7	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ARHGAP42 COL5A2 ITGA1 ZFPM2 PIEZO2 DST PTPRG	3.41e-06	199	141	7	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK2 SAMD9 TUT7 BIN2 TNFAIP6 LONRF3 FYB1	3.41e-06	199	141	7	e1240bfcdce76ec018599c50350748f9c7b8fb0e
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR SAMD9 TRIP11 BPTF SYNE2 ZFR BOD1L1	3.41e-06	199	141	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	HIVEP2 MED13L SKIL RESF1 SRGAP1 SYNE2 TNFAIP6	3.53e-06	200	141	7	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 ZFPM2 PIEZO2 DST PTPRG SRGAP1 NAV3	3.53e-06	200	141	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIK2 GRIK3 ITGA1 PIEZO2 ZNF608 SRGAP1 PCDH11X	3.53e-06	200	141	7	6a44439e4a7ce3627271375b04cfcfb9467218f4
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	HIVEP2 SLCO2B1 ITGA1 IFI16 EFNB1 ZNF608 SYNE2	3.53e-06	200	141	7	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ITGA1 IFI16 DST EFNB1 RESF1 ZNF608 SYNE2	3.53e-06	200	141	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	ZNF609 HIVEP2 SAMD9 DGKA DST TRAT1 SYNE2	3.53e-06	200	141	7	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIK2 GRIK3 ITGA1 PIEZO2 ZNF608 SRGAP1 PCDH11X	3.53e-06	200	141	7	8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	VPS13C MED13L SP110 BPTF RESF1 SYNE2 BOD1L1	3.53e-06	200	141	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 ELMO1 ZFPM2 PIEZO2 DST SRGAP1 NAV3	3.53e-06	200	141	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIK2 GRIK3 ITGA1 PIEZO2 ZNF608 SRGAP1 PCDH11X	3.53e-06	200	141	7	cb1f4b0d66da5b0466ff17b29e7034d451d93e4f
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK2 SLCO2B1 MED13L ELMO1 SRGAP1 NAV3 FYB1	3.53e-06	200	141	7	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 ITGA1 ELMO1 PIEZO2 DST SRGAP1 NAV3	3.53e-06	200	141	7	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ASH1L TRIP11 BPTF SYNE2 ZFR BOD1L1	5.21e-06	138	141	6	817e3f639604ea95adae01e8685ffaa2e0aff7a8
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ASH1L ATAD2 TRIP11 RIF1 DST SYNE2	2.29e-06	50	84	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ASH1L ANKRD36C BPTF RIF1 DST	4.15e-05	50	84	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Disease	Malignant neoplasm of breast	AKAP6 SLCO2B1 GRIK2 GRIK3 ZNF318 ARID1A KCNIP3 SP110 MAP3K1 NCOR1 PARP1 RIF1 ZNF532 SYNE2 BOD1L1 LONRF3 CLSPN CNGA2	2.87e-06	1074	138	18	C0006142
Disease	Intellectual Disability	AKAP6 HIVEP2 ASH1L GON4L SPECC1L MED13L BRWD3 BPTF PARP1 EPB41L1 ZMYM6	8.75e-06	447	138	11	C3714756
Disease	Adenocarcinoma Of Esophagus	DOCK2 ARID1A ELMO1	3.51e-05	14	138	3	C0279628
Disease	unipolar depression	HIVEP2 KCNH8 ASH1L GRIK2 GRIK3 TRIP11 ZFPM2 USP31 BPTF TRMT10C PIEZO2 PTPRG ZNF608 FIG4 SYNE2 ZFHX3 FYB1	5.03e-05	1206	138	17	EFO_0003761
Disease	blood rubidium measurement	RIF1 TNFAIP6 LRIF1	2.41e-04	26	138	3	EFO_0021529
Disease	galectin-7 measurement	APOB ZFPM2	3.22e-04	6	138	2	EFO_0022034
Disease	Drug-Induced Stevens Johnson Syndrome	CUL1 ELMO1 PARP1	3.35e-04	29	138	3	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	CUL1 ELMO1 PARP1	3.35e-04	29	138	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	CUL1 ELMO1 PARP1	3.35e-04	29	138	3	C3658302
Disease	Toxic Epidermal Necrolysis	CUL1 ELMO1 PARP1	3.35e-04	29	138	3	C0014518
Disease	Stevens-Johnson Syndrome	CUL1 ELMO1 PARP1	3.70e-04	30	138	3	C0038325
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	CMAS SRGAP1	4.49e-04	7	138	2	DOID:1312 (implicated_via_orthology)
Disease	Gonadal Dysgenesis, 46,XY	MAP3K1 ZFPM2	5.97e-04	8	138	2	C0018054
Disease	cysteine measurement	GRIK3 NAV3	7.65e-04	9	138	2	EFO_0021000
Disease	synaptotagmin-11 measurement	GON4L ZFPM2	7.65e-04	9	138	2	EFO_0802108
Disease	neuroblastoma (is_implicated_in)	KIF1B ARID1A	9.53e-04	10	138	2	DOID:769 (is_implicated_in)
Disease	ovary epithelial cancer (is_implicated_in)	AKAP6 KIF1B	1.16e-03	11	138	2	DOID:2152 (is_implicated_in)
Disease	metabolic rate measurement	SP110 ARPC2	1.16e-03	11	138	2	EFO_0005115
Disease	46,XY partial gonadal dysgenesis	MAP3K1 ZFPM2	1.16e-03	11	138	2	C4510744
Disease	overall survival, pancreatic carcinoma	PAIP2B BRD8 ZNF608	1.58e-03	49	138	3	EFO_0000638, EFO_0002618
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	HIRA PI4KA	1.90e-03	14	138	2	DOID:0060413 (implicated_via_orthology)
Disease	immature platelet fraction	KIF1B ZFPM2 ARPC2 BIN2	2.05e-03	114	138	4	EFO_0009187
Disease	triglycerides in LDL measurement	APOB BPTF SYNE2	2.31e-03	56	138	3	EFO_0022320
Disease	creatine kinase measurement	AKAP6 CNNM2 SPANXN3	2.69e-03	59	138	3	EFO_0004534
Disease	sphingomyelin 14:0 measurement	SYNE2 ZFHX3	2.82e-03	17	138	2	EFO_0010390
Disease	angina pectoris	CNNM2 KCNH8 APOB BRWD3	2.87e-03	125	138	4	EFO_0003913
Disease	triglycerides in small VLDL measurement	APOB ARID1A BPTF	2.95e-03	61	138	3	EFO_0022145
Disease	age at menopause	TFAP2C RIF1 SLC26A8 PIK3CG BOD1L1 LRIF1	3.04e-03	302	138	6	EFO_0004704
Disease	phospholipids in large VLDL measurement	APOB ARID1A BPTF	3.09e-03	62	138	3	EFO_0022169
Disease	triglycerides in medium LDL measurement	APOB ARID1A BPTF	3.09e-03	62	138	3	EFO_0022322
Disease	cutaneous melanoma, hair color	MED13L MAP3K1 SYNE2	3.09e-03	62	138	3	EFO_0000389, EFO_0003924
Disease	progression free survival, ovarian carcinoma	ELMO1 ARMH4	3.16e-03	18	138	2	EFO_0001075, EFO_0004920
Disease	disease free survival	WBP11 CCDC168	3.16e-03	18	138	2	EFO_0000409
Disease	prostate carcinoma	DOCK2 OGFRL1 WBP11 SKIL MAP3K1 RIF1 SYNE2 ZFHX3 ANKRD36 TNFAIP6 LRIF1	3.19e-03	891	138	11	EFO_0001663
Disease	unipolar depression, response to bupropion, mood disorder	NAV3 FYB1	3.52e-03	19	138	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	colorectal cancer, inflammatory bowel disease	GRIK2 SP110	3.52e-03	19	138	2	EFO_0003767, MONDO_0005575
Disease	triglycerides in small LDL measurement	APOB ARID1A BPTF	3.54e-03	65	138	3	EFO_0022323
Disease	platelet measurement	KIF1B ELMO1 ZFPM2 ARPC2 PARP1 BIN2	3.74e-03	315	138	6	EFO_0005036
Disease	ovarian carcinoma	IFI16 TFAP2C BRD8 PTPRG SERPINB11 ZFHX3	4.10e-03	321	138	6	EFO_0001075
Disease	Parkinson disease	COL5A2 ASH1L KCNIP3 EFNB1 RESF1 ZNF608	4.10e-03	321	138	6	MONDO_0005180
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	APOB SPECC1L ARID1A BPTF SYNE2	4.13e-03	224	138	5	EFO_0004530, EFO_0008317
Disease	age-related hearing impairment	DOCK2 SAMD9 ZNF318 MED13L ZFPM2 FIG4	4.29e-03	324	138	6	EFO_0005782
Disease	Bladder Neoplasm	VWA3A ARID1A BPTF NCOR1	4.30e-03	140	138	4	C0005695
Disease	sex interaction measurement, cerebral amyloid angiopathy	KCNH8 SRCIN1	4.30e-03	21	138	2	EFO_0006790, EFO_0008343
Disease	C-reactive protein measurement	AKAP6 VPS13C APOB CCDC168 ITGA1 IFI16 MAP3K1 ZFPM2 BPTF NCOR1 ZNF608 FYB1 ARMH4	4.39e-03	1206	138	13	EFO_0004458
Disease	Malignant neoplasm of urinary bladder	VWA3A ARID1A BPTF NCOR1	4.41e-03	141	138	4	C0005684
Disease	Malignant neoplasm of liver	ASH1L GRIK2 DICER1 NCOR1	4.52e-03	142	138	4	C0345904
Disease	stomach cancer (is_marker_for)	ARID1A DICER1 PARP1 EFNB1	4.52e-03	142	138	4	DOID:10534 (is_marker_for)
Disease	Liver neoplasms	ASH1L GRIK2 DICER1 NCOR1	4.52e-03	142	138	4	C0023903

Protein segments in the cluster

Peptide	Gene	Start	Entry
VSTKENGNGPMTVDK	PTPRG	1411	P23470
NEKEMLTSSLSKPSN	ABCA5	111	Q8WWZ7
SNSNSEPAKFMKNIG	ASH1L	751	Q9NR48
EDATMNGTSSQPKKE	CEP128	1076	Q6ZU80
SEPNNSSGSMEKRKS	ELMO1	336	Q92556
GDQSPADSNKTLEKM	TFAP2C	431	Q92754
SAGRSQKKMANSSPV	CWC25	206	Q9NXE8
SGKNVLMPSSKAVDD	CXorf58	131	Q96LI9
KSMGSQEDDSGNKPS	COPS3	406	Q9UNS2
KEEESFNIQNSMSPK	CSPG5	531	O95196
APSDSSVIAQQKAMK	CPSF2	666	Q9P2I0
TRKQDASEKDSVPMG	BRD8	836	Q9H0E9
TPDKEKPSQMTADNT	ARMH4	251	Q86TY3
SNPNGDKTKVMVSIS	ARPC2	46	O15144
GTQMKTKEFTSPQAE	GVINP1	221	Q7Z2Y8
GSTEQDAASPEKEKM	APLP1	526	P51693
MKENKENSSPSVTSA	CCNK	1	O75909
ASAPAMTTVENKSKI	SPECC1L	86	Q69YQ0
ATKMTGNNLPSGEDK	BRWD3	406	Q6RI45
ATKMKDVQTSTPAEQ	ANKRD36	1281	A6QL64
KATSDKEDSVPNMAT	ANKRD36B	536	Q8N2N9
MPKQNSTLVGDKRSD	ATAD2	1126	Q6PL18
MTTLSKSKQPSAAGN	LINC00313	1	P59037
GSEMVGKENSSPENK	DTL	646	Q9NZJ0
ANMETKPTGAQATDT	ANKRD24	616	Q8TF21
NANKSTSDGSPVMAV	DICER1	1246	Q9UPY3
LSETPDSSNMAEKKV	BPTF	661	Q12830
LMTSQVASEPGEAKK	BIN2	501	Q9UBW5
GINPTKSELASMAKD	CALML6	66	Q8TD86
SPFDVDKPSSMQKQT	DBF4	251	Q9UBU7
TTDSKENPSRKRNGM	ETNPPL	471	Q8TBG4
SSTSRDKAVKPAMNQ	BEND6	216	Q5SZJ8
KMEQENTAQGSEKPS	MSANTD5	16	A0A3B3IT52
MANTSPSVKSKEDQG	PAIP2B	6	Q9ULR5
NSSASADKPLSNMKI	PARP1	381	P09874
GQLSEKNSPKNMETS	KIAA1107	691	Q9UPP5
KNSPKNMETSESPES	KIAA1107	696	Q9UPP5
MNNKADGTPKTESKS	ARID1A	981	O14497
LKATSDKENSVPNMA	ANKRD36C	961	Q5JPF3
DKENSVPNMATETKD	ANKRD36C	966	Q5JPF3
KDLETNKATMVSQPS	CACNA1F	1656	O60840
MTTETGPDSEVKKAQ	EPB41L1	1	Q9H4G0
EGSKAQKMSSPLASS	OGFRL1	321	Q5TC84
KDSNAENMNSQPEKT	OGFRL1	396	Q5TC84
TKTEQPATKETSMKN	HCFC2	436	Q9Y5Z7
MPDSSSSGKNRKEES	LRP11	416	Q86VZ4
PDGKNAMSIFSSATK	MED13L	766	Q71F56
SSVMSDALKGNTGKP	LRIF1	61	Q5T3J3
NEIPKTSGSEMANKR	ZBTB33	461	Q86T24
EKSTSTQKDSPLNDM	DST	3016	Q03001
PATKLNTMSKTSLGQ	KIF1B	1231	O60333
ETSIMVKEPTNGSKS	CFAP57	231	Q96MR6
PQSQKAMQTKDASSD	ZFPM2	421	Q8WW38
SEGVKTAPSGQKSML	NAV3	371	Q8IVL0
EDESPMKNVSSSKGS	FYB1	211	O15117
SGPDRKNSKTSQKTM	DGKA	341	P23743
ESTLNVMSGKKSQPS	PI4KA	546	P42356
DPENMLATTNKTEKS	PPP4R3B	446	Q5MIZ7
TKVSAMDADSGPNAK	PCDH11X	486	Q9BZA7
EDPFSINSGKKMTTS	ITGA1	1036	P56199
SGRPKEMVSTSNNKD	INSL4	61	Q14641
NVIDRMKESSPSGSK	CHCHD3	31	Q9NX63
QKGMPKASFSNESSL	PRDM9	116	Q9NQV7
KGSENSQPEKMSQEL	POTEE	391	Q6S8J3
PSSSKLKVMQTDESN	BOD1L1	2906	Q8NFC6
GTNVDTKKMTSNFPV	APOB	1181	P04114
MGNAPAKKDTEQEES	PRKACG	1	P22612
EKMNTTSAPGDDVKN	DOCK2	1386	Q92608
QKETTEQSGKPIMSS	SLC1A7	121	O00341
TPTSMATVQKQKSGE	CUSTOS	211	Q96C57
STPVKMTDAGDSAKV	FIG4	776	Q92562
NAVTKMAQSSSKSPE	CUL1	406	Q13616
MEKGTTSKQDSTERP	C9orf43	361	Q8TAL5
PSKEADNTVKMATQA	EFNB1	181	P98172
VNKGSSKNALSSMDP	GON4L	1406	Q3T8J9
DKAETKNNPGKVSSM	ASCL3	151	Q9NQ33
KNNPGKVSSMIATTS	ASCL3	156	Q9NQ33
SSQIETMRSPDGSKK	COL5A2	1276	P05997
NKKDILNPDSSMETS	IFI16	766	Q16666
ASDRSKFQPQMSSKG	KIAA1210	1336	Q9ULL0
MEQISSGSSKAPNKE	CCDC168	941	Q8NDH2
GDSVNKDSMNATSTP	HIRA	531	P54198
DPASGLNMTESQKGK	GRIK2	406	Q13002
MSSKPSALVKNNEEG	GRIK3	711	Q13003
SSSPMNKAEEDGLSK	C4orf54	271	D6RIA3
KVESGKIQEPFSAMS	CEP295	801	Q9C0D2
MQPAKEVTKASDGSL	KCNIP3	1	Q9Y2W7
RNGSKDSLMEEKPQT	EPB41L4A	646	Q9HCS5
SKQGDPSKNSMTLDL	MAP3K1	1071	Q13233
AAIKNPGENESSKSM	GARIN3	316	Q8TC56
KNPSSKQMESSEGSS	RTL1	16	A6NKG5
GPVTEDKSSSKDMNS	SRGAP1	821	Q7Z6B7
KRNQSKTDAPSGMEL	SKIL	361	P12757
AKSDNQPSTEKAMEP	SYNE2	1071	Q8WXH0
SPDNIEKGMISSSKT	NBR1	486	Q14596
MDSVEKGAATSVSNP	CMAS	1	Q8NFW8
KSSGKMNGLVTSSPE	ARHGAP42	306	A6NI28
TSPEMSNSNNDERKK	RIF1	1161	Q5UIP0
TKSKENTMQESLPSG	RIF1	1816	Q5UIP0
SGQESSTKGMPAKSD	RESF1	651	Q9HCM1
DSIQTSKMGKPSKNA	SAMD9	81	Q5K651
KMSSSFLGSQKNVSP	SLC26A8	831	Q96RN1
DAAASAPQMDVSKTK	NCOR1	1826	O75376
QRFKGSENSQPEKMS	POTEJ	351	P0CG39
EMPSTSNGESSKQEA	RNF220	456	Q5VTB9
EQSAQKTKDMASLPS	SEC23IP	726	Q9Y6Y8
MEQPTSSINGEKRKS	SPANXN1	1	Q5VSR9
NQVKADLSGMSPTKG	SERPINB11	311	Q96P15
SEMNEGKRSQKTPST	SP110	356	Q9HB58
ETKSGVAPQKMAGAS	OS9	286	Q13438
MAPKGSSKQQSEEDL	SSR3	1	Q9UNL2
GDMTSSQVKTKPFDS	AKAP6	241	Q13023
KGSKDISSSEMTNPS	AKAP6	1826	Q13023
MASTALKSKSQPENE	AKAP6	2066	Q13023
MTEKTNGVKSSPANN	CNGA2	1	Q16280
PASSELNKQEKESSM	CLSPN	956	Q9HAW4
MDKTPQSSDSENTKI	CNNM2	821	Q9H8M5
KLTSATNPDKENSMS	PIK3CG	501	P48736
LDSGKKPSEQTASVM	ZNF532	386	Q9HCE3
AMDPVSKSSQGKNTS	TNFAIP6	246	P98066
VNKGSSNSPKMVEDK	REV3L	1976	O60673
AQQQATKPSKEMSGS	SRCIN1	1136	Q9C0H9
QTPSEAMSQKAKETV	SARG	241	Q9BW04
DKETKATMGTENTPG	SLCO2B1	16	O94956
MEQPTSSTNGEKTKS	SPANXN3	1	Q5MJ09
STPSKVTAAAMAGNK	TPR	1676	P12270
MEQPTSSTNGEKRKS	SPANXN2	1	Q5MJ10
AKMIAGNSTESSKTP	PIEZO2	2566	Q9H5I5
KNKPLSDMELNSSSE	ZNF609	441	O15014
NKTDMPSNKGIFEDT	ZDBF2	311	Q9HCK1
GMDASISVKPKQTDV	VPS13C	1626	Q709C8
PEKSVNKMQEATPSA	TRAT1	86	Q6PIZ9
KENDSSSNNKAMTDP	USP37	221	Q86T82
SNTKVSAVPTNMAAK	ZFR	481	Q96KR1
GSSAGDKMKTIPLSN	ZMYM6	866	O95789
QPSAVKQSDTMTEKE	TRIP11	361	Q15643
SMKQTGVDPTSRFKQ	ZNF608	1221	Q9ULD9
LSSPTQTAAKQGKMD	USP31	431	Q70CQ4
QTAAKQGKMDSPTSR	USP31	436	Q70CQ4
QGKMDSPTSRAGSDK	USP31	441	Q70CQ4
TTPPSASQSQAMDKK	TMC2	836	Q8TDI7
AMDKKAQGPGTSNSA	TMC2	846	Q8TDI7
TSSTKSGKFMNPTDQ	WBP11	6	Q9Y2W2
PKMTKSTQTQDSFQE	ZNF354B	91	Q96LW1
SSSKGSVEEIMSQPK	TEX2	746	Q8IWB9
SEMEAGSPENKKQRS	TUT7	166	Q5VYS8
SKGDVDPSQTSMLKS	HIVEP2	481	P31629
STGTPEAAKKDGTMN	TG	531	P01266
SFVDKSMQPGTSLAK	TRMT10C	311	Q7L0Y3
EQSNKLMTGSETPSK	ZNF318	1836	Q5VUA4
SSGPQKEEFQKDLMS	VWA3A	181	A6NCI4
KSSSAPNEGLTKAAM	ZFHX3	2866	Q15911
SNKSMVSQSEPKGNG	KCNH8	686	Q96L42
IESQEETGMPNKASK	LONRF3	426	Q496Y0